台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效

健亞

(4130)
可現股當沖
  • 股價
    24.05
  • 漲跌
    ▲0.05
  • 漲幅
    +0.21%
  • 成交量
    209
  • 產業
    上櫃 生技醫療類股
  • 150人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
健亞 (4130)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/18     後一日»

券商獲利排行 - 2024/04/18

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.01%4.904.9-2002024.3024.324.1
  0.79%2.302.3-1201224.2024.224.1
  0.95%1.901.9-80824.3024.324.1
  0.93%1.401.4-60624.3024.324.1
  0.86%1.301.3-60624.3024.324.1
  0.41%101-1001024.2024.224.1
  0.82%101-50524.3024.324.1
  1.03%101-40424.3024.324.1
  0.70%0.900.9-50524.2024.224.1
  1.23%0.600.6-20224.4024.424.1
  1.13%0.600.6-20224.3024.324.1
  1.03%0.500.5-20224.3024.324.1
  1.03%0.500.5-20224.3024.324.1
  0.16%0.50.9-0.43131024.224.224.324.1
  0.93%0.500.5-20224.3024.324.1
  0.82%0.400.4-20224.3024.324.1
  0.72%0.40.10.3-11224.324.224.324.1
  1.23%0.300.3-10124.4024.424.1
  1.23%0.300.3-10124.4024.424.1
  1.23%0.300.3-10124.4024.424.1
  1.23%0.300.3-10124.4024.424.1
  1.23%0.300.3-10124.4024.424.1
  1.03%0.300.3-10124.3024.324.1
  1.03%0.300.3-10124.3024.324.1
  1.03%0.300.3-10124.3024.324.1
  1.03%0.300.3-10124.3024.324.1
  1.03%0.300.3-10124.3024.324.1
  1.03%0.300.3-10124.3024.324.1
  0.82%0.200.2-10124.3024.324.1
  0.31%0.200.2-11224.224.224.224.1
  0.62%0.200.2-10124.2024.224.1
  0.62%0.20.2001124.224.224.324.1
  0.21%0.10.1001124.324.324.424.1
   00000024.224.224.224.1
   00000024.2024.224.1
   00000025.8025.824.1
   00000024.1024.124.1
   00000024.2024.224.1
   00000024.2024.224.1
   00000025.825.8024.1
   00000024.2024.224.1
   00000024.224.2024.1
   00000024.124.1024.1
   00000024.224.2024.1
   0000002525024.1
   00000024.124.1024.1
   00000024.124.1024.1
   00000024.224.2024.1
   00000024.224.2024.1
  0.00%00002224.324.324.324.1

券商虧損排行 - 2024/04/18

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -0.64%-3.6-0.1-3.51523824.324.324.324.1
  -1.05%-3.10-3.11212024.324.3024.1
  -1.03%-2.50-2.51010024.324.3024.1
  -1.03%-1.80-1.877024.324.3024.1
  -1.15%-1.40-1.455024.324.3024.1
  -1.03%-1.30-1.355024.324.3024.1
  -0.91%-1.10-1.155024.324.3024.1
  -1.03%-0.80-0.833024.324.3024.1
  -0.72%-0.70-0.744024.224.2024.1
  -0.62%-0.60-0.644024.224.2024.1
  -1.03%-0.50-0.522024.324.3024.1
  -0.82%-0.40-0.422024.324.3024.1
  -0.82%-0.40-0.422024.324.3024.1
  -0.82%-0.40-0.422024.324.3024.1
  -0.72%-0.40-0.422024.224.2024.1
  -1.23%-0.30-0.311024.424.4024.1
  -1.23%-0.30-0.311024.424.4024.1
  -1.23%-0.30-0.311024.424.4024.1
  -1.23%-0.30-0.301024.424.42524.1
  -1.03%-0.30-0.311024.324.3024.1
  -1.03%-0.30-0.311024.324.3024.1
  -1.03%-0.30-0.311024.324.3024.1
  -1.03%-0.30-0.311024.324.3024.1
  -1.03%-0.30-0.311024.324.3024.1
  -1.03%-0.30-0.311024.324.3024.1
  -0.82%-0.20-0.211024.324.3024.1
  -0.82%-0.20-0.211024.324.3024.1
  -0.82%-0.20-0.211024.324.3024.1
  -0.82%-0.20-0.211024.324.3024.1
  -0.82%-0.20-0.211024.324.3024.1
  -0.62%-0.20-0.211024.224.2024.1
  -0.62%-0.20-0.211024.224.2024.1
  -0.62%-0.20-0.211024.224.2024.1
  -0.62%-0.20-0.211024.224.2024.1
  -0.62%-0.20-0.211024.224.2024.1
   00000024.2024.224.1
   00000024.2024.224.1
   00000024.2024.224.1
   00000024.224.2024.1
   00000024.224.224.224.1
   00000024.2024.224.1
   00000024.224.2024.1
   00000024.124.1024.1
   00000024.224.2024.1
   00000025.825.8024.1
   00000024.2024.224.1
   00000024.224.2024.1
   0000002525024.1
   00000024.124.1024.1
   00000024.124.1024.1
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章